DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  x                             Filed by a party other than the Registrant  ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material Pursuant to §240.14a-12

Nektar Therapeutics

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 23, 2016

 

                           
 

 

NEKTAR THERAPEUTICS

   

    Meeting Information        
        

 

  Meeting Type: Annual Meeting

        
        

 

  For holders as of: April 26, 2016

       
        

 

  Date: June 23, 2016                 Time: 2:00 PM PDT

       
        

 

  Location:  Nektar Therapeutics

       
 

 

   LOGO

      

 

                       455 Mission Bay Blvd South

 

                       San Francisco, CA 94158

       
                
                      
 

 

   

 

          
 

NEKTAR THERAPEUTICS

ATTN: SECRETARY

455 MISSION BAY BOULEVARD SOUTH

SAN FRANCISCO, CA 94158

   

 

You are receiving this communication because you hold shares in the above named company.

LOGO     

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

    

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

      

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

 

    

     

—  Before You Vote  —

How to Access the Proxy Materials

 

    

Proxy Materials Available to VIEW or RECEIVE:

    
    

1. Notice & Proxy Statement        2. 10K Wrap

    
    

How to View Online:

    
    

Have the information that is printed in the box marked by the arrow  LOGO (located on the following page) and visit: www.proxyvote.com.

    
    

How to Request and Receive a PAPER or E-MAIL Copy:

    
    

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

    
    

1)  BY INTERNET:

  

www.proxyvote.com

    
    

2)  BY TELEPHONE:

  

1-800-579-1639

   
    

3)  BY E-MAIL*:

  

sendmaterial@proxyvote.com

   
    

*   If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

    
    

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 09, 2016 to facilitate timely delivery.

 

    
        

LOGO

 

 

     

—  How To Vote  —

Please Choose One of the Following Voting Methods

 

  
          
    

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

    
        

 

  Voting items   
 

 

The Board of Directors recommends you vote FOR the following:

 

 

1.

  

 

Election of Directors

   

 

Nominees

 

 

1a.

  

 

R. Scott Greer

 

 

1b.

  

 

Christopher A. Kuebler

 

 

1c.

  

 

Lutz Lingnau

 

 

The Board of Directors recommends you vote FOR proposals 2 and 3.

 

 

2

  

 

To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016.

 

 

3

  

 

To approve a non-binding advisory resolution regarding our executive compensation (a “say-on-pay” vote).

 

LOGO

   

 

 

 

 

 

    
    

 

LOGO